Capstone Investment Advisors
DNA icon

Capstone Investment Advisors’s Ginkgo Bioworks DNA Stock Holding History

Capstone Investment Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,099
Closed -$242K – 1981
2024
Q2 		$242K Buy
18,099
+14,933
+472% +$446K ﹤0.01% 1694
2024
Q1 		$147K Buy
+3,166
New +$164K ﹤0.01% 2077
2023
Q4 		– Sell
-1,743
Closed -$126K – 2165
2023
Q3 		$126K Buy
+1,743
New +$139K ﹤0.01% 1915
2021
Q4 		– Sell
-1,068
Closed -$495K – 1895
2021
Q3 		$495K Buy
+1,068
New +$520K ﹤0.01% 1551

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capstone Investment Advisors's DNA Position: Q3 2024 in Review

Capstone Investment Advisors sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 18,099 shares — an estimated $242K sold.

Capstone Investment Advisors first reported a position in DNA in Q3 2021 and held it in 4 quarters. The position peaked at $495K in Q3 2021. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Capstone Investment Advisors reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 18,099 Ginkgo Bioworks shares in Q3 2024, an estimated $242K.
  • Capstone Investment Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 4 quarters.
  • Capstone Investment Advisors's Ginkgo Bioworks position peaked at $495K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Capstone Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.